Issuance of 33B KRW Convertible Bonds & Acquisition of HanYang Robotics Leads to Soaring Debt, Deteriorating Financial Health, and Dilution Risk
In January 2026, NAUROBOTICS issued 33 billion KRW in unregistered private convertible bonds (conversion price KRW 22,142, convertible into 1,490,380 shares) and concurrently acquired a 97.82% stake in HanYang Robotics for 7.34 billion KRW, consolidating it as a subsidiary.
As a result, total consolidated liabilities surged from KRW 15.8 billion at end-2025 to KRW 74.4 billion at end-Q1 2026, with the debt-to-equity ratio skyrocketing from 98% to 568%. Derivative liabilities of KRW 23.25 billion and goodwill of KRW 7.58 billion were recognized from the convertible bond and acquisition, respectively.
Consolidated net loss expanded to KRW 3.2 billion from KRW 1.4 billion in the prior-year period, and operating cash flow remained negative at KRW 4.2 billion. Basic loss per share worsened to KRW 242.
The convertible bonds include early redemption rights (from July 2028) and put options (from January 2027), which could trigger anti-dilution adjustments if the stock price falls. The current price of KRW 22,000 is slightly below the conversion price.
The HanYang Robotics acquisition aims to strengthen industrial robot manufacturing capabilities; however, the subsidiary's liabilities exceed its assets (KRW 21.5 billion) and it recorded a net loss of KRW 1.1 billion in Q1, posing challenges to near-term profitability.
While the company continues to invest in its second factory (approx. KRW 11.5 billion) and R&D, total financial debt (including borrowings of KRW 19.6 billion and convertible bonds) reached KRW 65.4 billion, leading to a 16-fold increase in interest expense to KRW 784 million versus KRW 49 million a year ago.
No share buybacks or dividends have been announced. The largest shareholder's stake stands at 44.77%, but conversion of the CB would inevitably dilute equity.
[AI Summary]NAUROBOTICS expanded its scale through massive convertible bond issuance and M&A, but the resulting surge in debt and deepening operating losses have severely impaired its financial health. Although short-term liquidity was secured, the potential dilution from the convertible bonds (up to 1,490,380 shares, 11.5% of outstanding) and high debt ratio (568%) pose significant risks to shareholders.